TURIN, Italy--(BUSINESS WIRE)--Laife Reply, a company within the Reply Group focused on using AI, Big Data and Machine Learning to innovate preventive healthcare and treatment processes has developed, in collaboration with IEO (European Institute of Oncology), the Value Based Medicine (VBM), a web platform to support the patient care cycle..

意大利都灵--（商业新闻短讯）--Reply集团旗下的Laife Reply公司专注于利用人工智能、大数据和机器学习来创新预防性医疗保健和治疗流程，与IEO（欧洲肿瘤研究所）合作开发了基于价值的医学（VBM），这是一个支持患者护理周期的网络平台。。

The platform's objective is to use clinical information to predict, through statistical and artificial intelligence models, the outcomes of therapeutic and interventional treatment options, prioritising the patient's quality of life, both in terms of health and psychophysical well-being.

该平台的目标是利用临床信息，通过统计和人工智能模型预测治疗和介入治疗方案的结果，优先考虑患者的生活质量，包括健康和心理健康。

The project by Laife Reply and IEO embodies the principles of value-based medicine. It implements, in a software platform, methods for measuring the improvement of patient care outcomes. These methods are derived not only from the analysis of clinical data produced during the treatment of the pathology, but also from the analysis of the patient's quality of life resulting from it.

Laife Reply和IEO的项目体现了基于价值的医学原则。它在软件平台上实现了衡量患者护理结果改进的方法。这些方法不仅来源于对病理治疗过程中产生的临床数据的分析，还来源于对患者生活质量的分析。

The goal of value-based medicine is to create more 'value' for patients, enabling them to have a better quality of life, while at the same time ensuring the appropriateness of care..

基于价值的医学的目标是为患者创造更多的“价值”，使他们拥有更好的生活质量，同时确保护理的适当性。。

Among the main distinctive features of the platform is the ability to determine the probability of post-operative complications through artificial intelligence models, monitoring the patient's health status through periodic surveys, and supporting the patient by showing them the subsequent checkpoints of their care pathway.

该平台的主要特点之一是能够通过人工智能模型确定术后并发症的可能性，通过定期调查监测患者的健康状况，并通过向患者展示其护理路径的后续检查点来支持患者。

The AI tools adopted allow dynamically defining predictive models for each patient, effectively creating a personalised value measurement pathway..

采用的人工智能工具可以为每位患者动态定义预测模型，有效地创建个性化的价值衡量途径。。

The platform was first implemented with urological surgery data starting in 2019 and subsequently applied to breast and thoracic surgery. The Institute's goal is to extend it to all surgeries so that VBM can become a 'general purpose' platform.

该平台首先于2019年开始使用泌尿外科手术数据实施，随后应用于乳房和胸部手术。该研究所的目标是将其扩展到所有手术，以便VBM可以成为“通用”平台。

Since September 2023, IEO has started the certification process of the platform as a medical device. In addition, in November 2023, VBM received the Agenas (National Agency for Regional Health Services) and Sics (Italian Society of Scientific and Health Communication) Award for Innovation in Digital Health.

自2023年9月以来，IEO开始了该平台作为医疗器械的认证过程。此外，2023年11月，VBM获得了Agenas（国家区域卫生服务机构）和Sics（意大利科学与卫生传播学会）数字健康创新奖。

Thanks to ongoing developments, supported by the IEO working group and Laife Reply's technological expertise, the project is significantly contributing to improving access to healthcare services and the quality of care, ensuring citizens receive personalised and attentive care, delivered with increasing efficiency.

由于IEO工作组和Laife Reply的技术专业知识的支持，该项目正在不断发展，大大有助于改善医疗服务的获得和护理质量，确保公民获得个性化和周到的护理，提高效率。

Tangibility, sustainability, and replicability are the main qualities recognised in the platform that have led to its recognition..

有形性、可持续性和可复制性是该平台认可的主要品质，也是该平台获得认可的原因。。

Finally, it is essential for the digital transformation undertaken by the Institute that the VBM platform integrates with the Clinical Data Platform, CDP, the IEO Datalake of clinical data and real-world data, also developed by Laife Reply, which represents for IEO the interoperable digital ecosystem for the care, prevention, and research of oncological pathologies..

最后，VBM平台与临床数据平台、CDP、临床数据和现实世界数据的IEO Datalake（也是由Laife Reply开发的）相结合，对于该研究所进行的数字转型至关重要，它代表了IEO用于肿瘤病理学护理、预防和研究的可互操作数字生态系统。。

Reply

答复

Reply [EXM, STAR: REY] specialises in the design and implementation of solutions based on new communication channels and digital media. Reply is a network of highly specialised companies supporting key European industrial groups operating in the telecom and media, industry and services, banking, insurance and public administration sectors in the definition and development of business models enabled for the new paradigms of big data, cloud computing, digital media and the Internet of Things.

Reply[EXM，STAR:REY]专注于基于新通信渠道和数字媒体的解决方案的设计和实施。Reply是一个高度专业化的公司网络，支持在电信和媒体、工业和服务、银行、保险和公共管理部门运营的关键欧洲工业集团定义和开发商业模式，以实现大数据、云计算、数字媒体和物联网的新范式。

Reply services include: Consulting, System Integration and Digital Services. www.reply.com.

回复服务包括：咨询、系统集成和数字服务。www.reply.com。

Laife Reply

莱夫回复

Laife Reply, a company within the Reply group, operates in the Health, Welfare, and Pharma sectors and develops artificial intelligence solutions ranging from Medical Imaging, Drug Discovery, Digital Therapeutics to Natural Language Processing for the analysis of unstructured data.

莱夫·Reply是Reply集团旗下的一家公司，经营健康、福利和制药行业，开发人工智能解决方案，从医学成像、药物发现、数字治疗到自然语言处理，用于分析非结构化数据。